-
1641“…Visceral leishmaniasis (VL) has rarely been reported in patients with chronic granulomatous disease (CGD), despite the fact that they seem more susceptible to intracellular infection. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1642por Elfaki, Nahid, Alzahrani, Mohammed, Abdalla, Yahya Hussein Ahmed, Alkhadher, Mugahed Ali, Osman, Abdalla MohamedAhmed, Taha, Wargaa, Alghamdi, Wael, Alshameri, Faroq Abdulghani, Ahmed, Waled A. M.“…BACKGROUND: Cutaneous leishmaniasis (CL) is a parasitic disease transmitted through the bite of infected sandflies, causing disfiguring skin lesions and a range of physical symptoms. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1643por Yizengaw, Endalew, Nibret, Endalkachew, Yismaw, Gizachew, Gashaw, Bizuayehu, Tamiru, Dessalegn, Munshea, Abaineh, Takele, Yegnasew, Müller, Ingrid, Chapman, Lloyd, Weller, Richard, Cotton, James A., Kropf, Pascale“…BACKGROUND: Cutaneous leishmaniasis (CL) is a neglected tropical disease that primarily affects the most vulnerable populations. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1644por Lehlewa, Asaad Mahdi, Khaleel, Hanan Abdulghafoor, Lami, Faris, Hasan, Saif Aldeen Falah, Malick, Hasanain Asmail, Mohammed, Razzaq Hashim, Abdulmottaleb, Qais Abdulazziz“…BACKGROUND: In 2018, an outbreak of cutaneous leishmaniasis (CL) occurred in Diyala Province in Iraq. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1645“…BACKGROUND: Visceral leishmaniasis (Kala-azar) is an inherently dangerous and progressive disease that can be seen in many parts of the world, including Iran. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1646por Nunes, Sara, Tibúrcio, Rafael, Bonyek-Silva, Icaro, Oliveira, Pablo Rafael, Khouri, Ricardo, Boaventura, Viviane, Barral, Aldina, Brodskyn, Cláudia, Tavares, Natalia Machado“…Skin ulcers of cutaneous leishmaniasis (CL) are characterized by a localized inflammatory response mediated by innate and adaptive immune cells, including dendritic cells (DC) and natural killer (NK) cells. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1647por da Silva, João Guilherme Lino, Gonçalves, Ana Alice Maia, Oliveira, Liliam Teixeira, Garcia, Giani Martins, Batista, Maurício Azevedo, de Mendonça, Ludmila Zanandreis, Viana, Kelvinson Fernandes, Sant’Ana, Rita de Cássia Oliveira, Melo Júnior, Otoni Alves de Oliveira, Silveira-Lemos, Denise, Dutra, Walderez Ornelas, Martins-Filho, Olindo Assis, Galdino, Alexsandro Sobreira, de Moura, Sandra Aparecida Lima, Mosqueira, Vanessa Carla Furtado, Giunchetti, Rodolfo CordeiroEnlace del recurso
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1648por Cossio, Alexandra, Bautista-Gomez, Martha Milena, Alexander, Neal, del Castillo, Alejandra María, Castro, María del Mar, Castaño-Grajales, Patricia Yaneth, Gutiérrez-Poloche, Yeison Hawer, Zuluaga, Laura Sofía, Vargas-Bernal, Leonardo, Navarro, Andrés, Saravia, Nancy Gore“…Cutaneous leishmaniasis (CL) remains a global health problem. Compelled by the protracted healing process, initial and final outcomes of treatment are determined at 90 and 180 days, respectively, after initiation of treatment. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1649
-
1650por van Henten, Saskia, Pareyn, Myrthe, Tadesse, Dagimawie, Kassa, Mekidim, Techane, Mehret, Kinfe, Eyerusalem, Girma, Nigatu, Demeke, Degnet, Mesay, Mebratu, Kassa, Mekibib, Temesgen, Rodas, Shewangizaw, Misgun, Massebo, Fekadu, van Griensven, Johan, Wegayehu, Teklu, Merdekios, Behailu“…BACKGROUND: Cutaneous leishmaniasis (CL) is a common, yet massively underreported skin morbidity in Ethiopia. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1651por Alemu, Abebaw Yeshambel, Derseh, Lemma, Kaba, Mirgissa, Gadisa, Endalamaw, Alemu, Kassahun“…BACKGROUND: Leishmania aethiopica is a unique species that causes cutaneous leishmaniasis (CL), and studies evaluating treatment outcomes for this condition reported inconsistent findings. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1652por Verrest, Luka, Roseboom, Ignace C, Wasunna, Monique, Mbui, Jane, Njenga, Simon, Musa, Ahmed M, Olobo, Joseph, Mohammed, Rezika, Ritmeijer, Koert, Chu, Wan-Yu, Huitema, Alwin D R, Solomos, Alexandra, Alves, Fabiana, Dorlo, Thomas P C“…OBJECTIVES: To improve visceral leishmaniasis (VL) treatment in Eastern Africa, 14- and 28-day combination regimens of paromomycin plus allometrically dosed miltefosine were evaluated. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1653por Roberts, Tamalee, Keddie, Suzanne H., Rattanavong, Sayaphet, Gomez, Santiago Rayment, Bradley, John, Keogh, Ruth H., Bärenbold, Oliver, Falconer, Jane, Mens, Petra F., Hopkins, Heidi, Ashley, Elizabeth A.“…BACKGROUND: Parasitological investigation of bone marrow, splenic or lymph node aspirations is the gold standard for the diagnosis of visceral leishmaniasis (VL). However, this invasive test requires skilled clinical and laboratory staff and adequate facilities, and sensitivity varies depending on the tissue used. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1654por Doni, Shimelis, Yeneneh, Kidist, Hailemichael, Yohannes, Gebremichael, Mikyas, Skarbek, Sophie, Ayele, Samuel, Tadesse, Abay Woday, Lambert, Saba, Walker, Stephen L., Gadisa, Endalamaw“…BACKGROUND: Cutaneous leishmaniasis (CL) is a growing public health threat in Ethiopia. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1655por Vlassoff, Carol, Giron, Nora, Vera Soto, Mauricio Javier, Maia-Elkhoury, Ana Nilce Silveira, Lal, Arush, Castellanos, Luis Gerardo, Almeida, Gisele, Lim, Christopher“…BACKGROUND: This paper identifies opportunities and challenges for leishmaniasis control and elimination in Colombia, emphasizing the role of pooled procurement of essential medicines and supplies. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1656por Caldas, Arlene, Favali, Cecília, Aquino, Dorlene, Vinhas, Vera, van Weyenbergh, Johan, Brodskyn, Cláudia, Costa, Jackson, Barral-Netto, Manoel, Barral, Aldina“…BACKGROUND: Leishmaniasis remains a serious public health problem in several parts of the developing world. …”
Publicado 2005
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1657por Hadighi, Ramtin, Mohebali, Mehdi, Boucher, Patrick, Hajjaran, Homa, Khamesipour, Ali, Ouellette, Marc“…BACKGROUND: Recent circumstantial evidence suggests that an increasing number of Iranian patients with cutaneous leishmaniasis are unresponsive to meglumine antimoniate (Glucantime), the first line of treatment in Iran. …”
Publicado 2006
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1658por Akiba, Hisaya, Miyahira, Yasushi, Atsuta, Machiko, Takeda, Kazuyoshi, Nohara, Chiyoko, Futagawa, Toshiro, Matsuda, Hironori, Aoki, Takashi, Yagita, Hideo, Okumura, Ko“…These results indicate that anti-OX40L mAb abrogated progressive leishmaniasis in BALB/c mice by suppressing the development of Th2 responses, substantiating a critical role of OX40–OX40L interaction in Th2 development in vivo.…”
Publicado 2000
Enlace del recurso
Enlace del recurso
Texto -
1659por Petersen, Christine A.“…Prevention of human clinical visceral leishmaniasis can occur only by better understanding the disease ecology of the primary reservoir host: the dog.…”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1660por Musa, Ahmed M., Younis, Brima, Fadlalla, Ahmed, Royce, Catherine, Balasegaram, Manica, Wasunna, Monique, Hailu, Asrat, Edwards, Tansy, Omollo, Raymond, Mudawi, Mahmoud, Kokwaro, Gilbert, El-Hassan, Ahmed, Khalil, Eltahir“…BACKGROUND: A recent study has shown that treatment of visceral leishmaniasis (VL) with the standard dose of 15 mg/kg/day of paromomycin sulphate (PM) for 21 days was not efficacious in patients in Sudan. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto